Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on: May 21,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on:May 21,2024

Potential markers identified for early detection and prevention of liver cancer

by FrontiersCredit: CC0 Public DomainLiver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cur

Updated on: March 09,2024

Potential markers identified for early detection and prevention of liver cancer

by FrontiersCredit: CC0 Public DomainLiver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cur

Updated on:March 09,2024

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Updated on: August 27,2024

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Updated on:August 27,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on: January 12,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on:January 12,2024

Scientists decode key mutation in many cancers, pointing to expanded role of RNA in human gene expression

byUniversity of ChicagoCredit: Unsplash/CC0 Public DomainInside every cell, inside every nucleus, your continued existence depends on an incredibly complicated dance. Proteins are constantly wra

Updated on: November 10,2024

Scientists decode key mutation in many cancers, pointing to expanded role of RNA in human gene expression

byUniversity of ChicagoCredit: Unsplash/CC0 Public DomainInside every cell, inside every nucleus, your continued existence depends on an incredibly complicated dance. Proteins are constantly wra

Updated on:November 10,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on: April 01,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on:April 01,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on: January 29,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on:January 29,2024

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on: May 23,2024

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on:May 23,2024

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs

Updated on: March 30,2024

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs

Updated on:March 30,2024

Research identifies cells that may be responsible for prostate cancer recurrence

by Roswell Park Cancer InstituteSlide illustrating resistance to androgen-deprivation therapy in a newly identified population of dormant prostate luminal stem cells. Credit: Roswell Park Cancer

Updated on: March 01,2024

Research identifies cells that may be responsible for prostate cancer recurrence

by Roswell Park Cancer InstituteSlide illustrating resistance to androgen-deprivation therapy in a newly identified population of dormant prostate luminal stem cells. Credit: Roswell Park Cancer

Updated on:March 01,2024

Implanted pump safely delivers chemo straight to brain in patients with brain cancer

byColumbia University Irving Medical CenterMRI scans show that chemotherapy delivered via the pump saturated the area in and around each patient's brain tumor. Top images show the brain befo

Updated on: January 02,2024

Implanted pump safely delivers chemo straight to brain in patients with brain cancer

byColumbia University Irving Medical CenterMRI scans show that chemotherapy delivered via the pump saturated the area in and around each patient's brain tumor. Top images show the brain befo

Updated on:January 02,2024